theragnostics

theragnostics

(ther″ăg-nos′tiks) [ therapy + diagnostics]
The use of molecular diagnostic techniques, e.g. the identification of the enzymes one person makes that another does not, to guide treatment decisions such as the choice of drugs that will be optimally metabolized by a particular patient.
References in periodicals archive ?
In the past few months several other key events have confirmed the trend of an increasing interest for the nuclear medicine market, such as Jubilant Pharma acquiring Triad Isotopes, Sofie Biosciences purchasing Zevacor Pharma, Theragnostics Ltd.
The application of mass-spectrometry-based protein biomarker discovery to theragnostics.
Jin, Magnetic nanoparticles for theragnostics, Adv Drug Deliv Rev, 61(6):467-77 (2009).
The effort to combine new biomarkers with complementary therapy has also led to the concept of theragnostics (a portmanteau of therapeutics and diagnostics).
About Theragnostics: An integral component of stratified medicine, theragnostics provide therapeutic guidance in drug development and patient treatment protocols by correlating either to the mechanism of action by which the therapies work, or to the underlying mechanism of onset, progression, and the pathophysiology of the disease itself.
Further, the emerging sectors like genetic testing is poised to give the potential growth for theragnostics and personalized medicine.
2) The full-integration of several areas of diagnostics, namely radiology, pathology, laboratory testing, and theragnostics (a term denoting the fusion of therapeutics and diagnostics) (3) will require construction of new and complex frameworks, where the potential to develop bottlenecks and system failures might increase substantially.
Further, the market has been witnessing greater importance in the emerging sectors like genetic testing which is poised to offer a potential growth for theragnostics and personalized medicine.
Further, the emerging sectors like genetic testing hold tremendous opportunities in the field of molecular diagnostics, theragnostics, and personalized medicine.
About Theragnostics: A theragnostic test can be a combination of molecular (or physiological) tests used to either select a patient for a particular therapy or administer a particular drug from a portfolio of customized drugs to subsets of patients.
An Overview of Key Emerging Technologies II-3 Bioinformatics II-3 Pharmacogenomics II-3 Theragnostics II-4 Targeted Therapy II-5 Mass Spectrometry - A New Catalyst for Technological Developments II-5
bioMerieux is very pleased to sign an important theragnostics partnership with Ipsen and bring a high medical value test to help advance cancer treatment options and improve patient prognosis," declared Stephane Bancel, Chief Executive Officer of bioMerieux.